Gastrointestinal Stromal Tumor Market

Global Market Study on Gastrointestinal Stromal Tumor: Stomach Indications to Account for Largest Revenue Share during 2017-2026

The gastrointestinal Stromal Tumor market is segmented by the indication that is Stomach, Small Intestine, and by treatments that are Targeted Drug Therapy, Chemotherapy, Radiation Therapy, Surgery.

  • December-2017
  • PMRREP20626
  • 170 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Table of Content

1. Global Economic Outlook

2. Global Gastrointestinal Stromal Tumor Market - Executive Summary

3. Global Gastrointestinal Stromal Tumor Market Overview
     3.1. Introduction
            3.1.1. Global Gastrointestinal Stromal Tumor Market Taxonomy
            3.1.2. Global Gastrointestinal Stromal Tumor Market Definition
     3.2. Global Gastrointestinal Stromal Tumor Market Size (US$ Mn) and Forecast, 2012-2026
            3.2.1. Global Gastrointestinal Stromal Tumor Market Y-o-Y Growth
     3.3. Global Gastrointestinal Stromal Tumor Market Dynamics
     3.4. Supply Chain
     3.5. Cost Structure
     3.6. Pricing Analysis
     3.7. Drug Pipeline Assessment
     3.8. PESTL Analysis
     3.9. List of Distributors
     3.10. Key Participant Market Presence (Intensity) Map

4. Global Gastrointestinal Stromal Tumor Market Analysis and Forecast 2012-2026 
     4.1. Global Gastrointestinal Stromal Tumor Market Size and Forecast By Indication, 2012-2026
            4.1.1. Stomach  Market Size and Forecast, 2012-2026
                     4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                     4.1.1.2. Market Share Comparison, By Region
                     4.1.1.3. Y-o-Y growth Comparison, By Region
            4.1.2. Small Intestine Market Size and Forecast, 2012-2026
                     4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                     4.1.2.2. Market Share Comparison, By Region
                     4.1.2.3. Y-o-Y growth Comparison, By Region
            4.1.3. Others  Market Size and Forecast, 2012-2026
                     4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                     4.1.3.2. Market Share Comparison, By Region
                     4.1.3.3. Y-o-Y growth Comparison, By Region
     4.2. Global Gastrointestinal Stromal Tumor Market Size and Forecast By End User, 2012-2026
            4.2.1. Hospitals  Market Size and Forecast, 2012-2026
                     4.2.1.1. Revenue (US$ Mn) Comparison, By Region
                     4.2.1.2. Market Share Comparison, By Region
                     4.2.1.3. Y-o-Y growth Comparison, By Region
            4.2.2. Clinics  Market Size and Forecast, 2012-2026
                     4.2.2.1. Revenue (US$ Mn) Comparison, By Region
                     4.2.2.2. Market Share Comparison, By Region
                     4.2.2.3. Y-o-Y growth Comparison, By Region
            4.2.3. Specialized Cancer Treatment Centers  Market Size and Forecast, 2012-2026
                     4.2.3.1. Revenue (US$ Mn) Comparison, By Region
                     4.2.3.2. Market Share Comparison, By Region
                     4.2.3.3. Y-o-Y growth Comparison, By Region
            4.2.4. Other End Users  Market Size and Forecast, 2012-2026
                     4.2.4.1. Revenue (US$ Mn) Comparison, By Region
                     4.2.4.2. Market Share Comparison, By Region
                     4.2.4.3. Y-o-Y growth Comparison, By Region
     4.3. Global Gastrointestinal Stromal Tumor Market Size and Forecast By Treatment Type, 2012-2026
            4.3.1. Targeted Drug Therapy  Market Size and Forecast, 2012-2026
                     4.3.1.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.1.2. Market Share Comparison, By Region
                     4.3.1.3. Y-o-Y growth Comparison, By Region
            4.3.2. Chemotherapy  Market Size and Forecast, 2012-2026
                     4.3.2.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.2.2. Market Share Comparison, By Region
                     4.3.2.3. Y-o-Y growth Comparison, By Region
            4.3.3. Radiation Therapy Market Size and Forecast, 2012-2026
                     4.3.3.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.3.2. Market Share Comparison, By Region
                     4.3.3.3. Y-o-Y growth Comparison, By Region
            4.3.4. Surgery  Market Size and Forecast, 2012-2026
                     4.3.4.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.4.2. Market Share Comparison, By Region
                     4.3.4.3. Y-o-Y growth Comparison, By Region
            4.3.5. Other Therapies Market Size and Forecast, 2012-2026
                     4.3.5.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.5.2. Market Share Comparison, By Region
                     4.3.5.3. Y-o-Y growth Comparison, By Region

5. North America Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026
     5.1. North America Outlook 
     5.2. North America Parent Market Outlook 
     5.3. North America Target Market Outlook 
     5.4. Revenue (US$ Mn) Comparison, By Country 
            5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
            5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
     5.5. Revenue (US$ Mn) Comparison, By Indication
     5.6. Revenue (US$ Mn) Comparison, By End User 
     5.7. Revenue (US$ Mn) Comparison, By Treatment Type

6. Latin America Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026
     6.1. Latin America Outlook 
     6.2. Latin America Parent Market Outlook 
     6.3. Latin America Target Market Outlook 
     6.4. Revenue (US$ Mn) Comparison, By Country 
            6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
            6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
            6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
     6.5. Revenue (US$ Mn) Comparison, By Indication
     6.6. Revenue (US$ Mn) Comparison, By End User 
     6.7. Revenue (US$ Mn) Comparison, By Treatment Type

7. Europe Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026
     7.1. Europe Outlook 
     7.2. Europe Parent Market Outlook 
     7.3. Europe Target Market Outlook 
     7.4. Revenue (US$ Mn) Comparison, By Country 
            7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
            7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
            7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
            7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
            7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
            7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
     7.5. Revenue (US$ Mn) Comparison, By Indication
     7.6. Revenue (US$ Mn) Comparison, By End User 
     7.7. Revenue (US$ Mn) Comparison, By Treatment Type

8. Japan Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026
     8.1. Japan Outlook 
     8.2. Japan Parent Market Outlook 
     8.3. Japan Target Market Outlook 
     8.4. Revenue (US$ Mn) Comparison, By Country 
            8.4.1. Japan  Market Size and Forecast (US$ Mn), 2012-2026
     8.5. Revenue (US$ Mn) Comparison, By Indication
     8.6. Revenue (US$ Mn) Comparison, By End User 
     8.7. Revenue (US$ Mn) Comparison, By Treatment Type

9. APEJ Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026
     9.1. APEJ Outlook 
     9.2. APEJ Parent Market Outlook 
     9.3. APEJ Target Market Outlook 
     9.4. Revenue (US$ Mn) Comparison, By Country 
            9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
            9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
            9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
            9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
            9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
            9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
     9.5. Revenue (US$ Mn) Comparison, By Indication
     9.6. Revenue (US$ Mn) Comparison, By End User 
     9.7. Revenue (US$ Mn) Comparison, By Treatment Type

10. MEA Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026
     10.1. MEA Outlook 
     10.2. MEA Parent Market Outlook 
     10.3. MEA Target Market Outlook 
     10.4. Revenue (US$ Mn) Comparison, By Country 
            10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
            10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
            10.4.3. Nigeria Market Size and Forecast (US$ Mn), 2012-2026
            10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
     10.5. Revenue (US$ Mn) Comparison, By Indication
     10.6. Revenue (US$ Mn) Comparison, By End User 
     10.7. Revenue (US$ Mn) Comparison, By Treatment Type

11. Global Gastrointestinal Stromal Tumor Market Company Share, Competition Landscape and Company Profiles
     11.1. Company Share Analysis
     11.2. Competition Landscape
     11.3. Company Profiles
            11.3.1. Novartis AG
            11.3.2. Sun Pharmaceutical Industries Limited
            11.3.3. Pfizer Inc.
            11.3.4. Bayer Aktiengesellschaft
            11.3.5. NATCO Pharma Limited

12. Research Methodology

13. Secondary and Primary Sources

14. Assumptions and Acronyms

15. Disclaimer

Find Out More about the Report Coverage

List of Tables

List of Table

TABLE 1: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn), 2012-2017

TABLE 2: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn), 2018-2026

TABLE 3: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn) and Y-o-Y, 2017-2026

TABLE 4: Global Stomach Segment Value (US$ Mn), By Region 2012-2017

TABLE 5: Global Stomach Segment Value (US$ Mn), By Region 2018-2026

TABLE 6: Global Stomach Segment Market Share, By Region 2012-2017

TABLE 7: Global Stomach Segment Market Share, By Region 2018-2026

TABLE 8: Global Stomach Segment Y-o-Y, By Region 2017-2026

TABLE 9: Global Small Intestine Segment Value (US$ Mn), By Region 2012-2017

TABLE 10: Global Small Intestine Segment Value (US$ Mn), By Region 2018-2026

TABLE 11: Global Small Intestine Segment Market Share, By Region 2012-2017

TABLE 12: Global Small Intestine Segment Market Share, By Region 2018-2026

TABLE 13: Global Small Intestine Segment Y-o-Y, By Region 2017-2026

TABLE 14: Global Others Segment Value (US$ Mn), By Region 2012-2017

TABLE 15: Global Others Segment Value (US$ Mn), By Region 2018-2026

TABLE 16: Global Others Segment Market Share, By Region 2012-2017

TABLE 17: Global Others Segment Market Share, By Region 2018-2026

TABLE 18: Global Others Segment Y-o-Y, By Region 2017-2026

TABLE 19: Global Hospitals Segment Value (US$ Mn), By Region 2012-2017

TABLE 20: Global Hospitals Segment Value (US$ Mn), By Region 2018-2026

TABLE 21: Global Hospitals Segment Market Share, By Region 2012-2017

TABLE 22: Global Hospitals Segment Market Share, By Region 2018-2026

TABLE 23: Global Hospitals Segment Y-o-Y, By Region 2017-2026

TABLE 24: Global Clinics Segment Value (US$ Mn), By Region 2012-2017

TABLE 25: Global Clinics Segment Value (US$ Mn), By Region 2018-2026

TABLE 26: Global Clinics Segment Market Share, By Region 2012-2017

TABLE 27: Global Clinics Segment Market Share, By Region 2018-2026

TABLE 28: Global Clinics Segment Y-o-Y, By Region 2017-2026

TABLE 29: Global Specialized Cancer Treatment Centers Segment Value (US$ Mn), By Region 2012-2017

TABLE 30: Global Specialized Cancer Treatment Centers Segment Value (US$ Mn), By Region 2018-2026

TABLE 31: Global Specialized Cancer Treatment Centers Segment Market Share, By Region 2012-2017

TABLE 32: Global Specialized Cancer Treatment Centers Segment Market Share, By Region 2018-2026

TABLE 33: Global Specialized Cancer Treatment Centers Segment Y-o-Y, By Region 2017-2026

TABLE 34: Global Other End Users Segment Value (US$ Mn), By Region 2012-2017

TABLE 35: Global Other End Users Segment Value (US$ Mn), By Region 2018-2026

TABLE 36: Global Other End Users Segment Market Share, By Region 2012-2017

TABLE 37: Global Other End Users Segment Market Share, By Region 2018-2026

TABLE 38: Global Other End Users Segment Y-o-Y, By Region 2017-2026

TABLE 39: Global Targeted Drug Therapy Segment Value (US$ Mn), By Region 2012-2017

TABLE 40: Global Targeted Drug Therapy Segment Value (US$ Mn), By Region 2018-2026

TABLE 41: Global Targeted Drug Therapy Segment Market Share, By Region 2012-2017

TABLE 42: Global Targeted Drug Therapy Segment Market Share, By Region 2018-2026

TABLE 43: Global Targeted Drug Therapy Segment Y-o-Y, By Region 2017-2026

TABLE 44: Global Chemotherapy Segment Value (US$ Mn), By Region 2012-2017

TABLE 45: Global Chemotherapy Segment Value (US$ Mn), By Region 2018-2026

TABLE 46: Global Chemotherapy Segment Market Share, By Region 2012-2017

TABLE 47: Global Chemotherapy Segment Market Share, By Region 2018-2026

TABLE 48: Global Chemotherapy Segment Y-o-Y, By Region 2017-2026

TABLE 49: Global Radiation Therapy Segment Value (US$ Mn), By Region 2012-2017

TABLE 50: Global Radiation Therapy Segment Value (US$ Mn), By Region 2018-2026

TABLE 51: Global Radiation Therapy Segment Market Share, By Region 2012-2017

TABLE 52: Global Radiation Therapy Segment Market Share, By Region 2018-2026

TABLE 53: Global Radiation Therapy Segment Y-o-Y, By Region 2017-2026

TABLE 54: Global Surgery Segment Value (US$ Mn), By Region 2012-2017

TABLE 55: Global Surgery Segment Value (US$ Mn), By Region 2018-2026

TABLE 56: Global Surgery Segment Market Share, By Region 2012-2017

TABLE 57: Global Surgery Segment Market Share, By Region 2018-2026

TABLE 58: Global Surgery Segment Y-o-Y, By Region 2017-2026

TABLE 59: Global Other Therapies Segment Value (US$ Mn), By Region 2012-2017

TABLE 60: Global Other Therapies Segment Value (US$ Mn), By Region 2018-2026

TABLE 61: Global Other Therapies Segment Market Share, By Region 2012-2017

TABLE 62: Global Other Therapies Segment Market Share, By Region 2018-2026

TABLE 63: Global Other Therapies Segment Y-o-Y, By Region 2017-2026

TABLE 64: North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 65: North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 66: North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 67: North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 68: North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 69: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017

TABLE 70: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026

TABLE 71: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017

TABLE 72: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026

TABLE 73: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017

TABLE 74: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026

TABLE 75: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017

TABLE 76: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026

TABLE 77: Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 78: Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 79: Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 80: Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 81: Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 82: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017

TABLE 83: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026

TABLE 84: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017

TABLE 85: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026

TABLE 86: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017

TABLE 87: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026

TABLE 88: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017

TABLE 89: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026

TABLE 90: Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 91: Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 92: Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 93: Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 94: Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 95: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017

TABLE 96: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026

TABLE 97: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017

TABLE 98: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026

TABLE 99: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017

TABLE 100: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026

TABLE 101: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017

TABLE 102: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026

TABLE 103: Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 104: Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 105: Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 106: Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 107: Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 108: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017

TABLE 109: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026

TABLE 110: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017

TABLE 111: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026

TABLE 112: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017

TABLE 113: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026

TABLE 114: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017

TABLE 115: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026

TABLE 116: APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 117: APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 118: APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 119: APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 120: APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 121: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017

TABLE 122: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026

TABLE 123: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017

TABLE 124: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026

TABLE 125: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017

TABLE 126: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026

TABLE 127: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017

TABLE 128: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026

TABLE 129: MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 130: MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 131: MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 132: MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 133: MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 134: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017

TABLE 135: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026

TABLE 136: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017

TABLE 137: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026

TABLE 138: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017

TABLE 139: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026

TABLE 140: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017

TABLE 141: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026

Explore Persistence Market Research’s expertise in promulgation of the business !

List of Chart

List of Figures

FIG. 1: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn), 2012-2017

FIG. 2: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn) Forecast, 2018-2026

FIG. 3: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn) and Y-o-Y, 2017-2026

FIG. 4: Global Stomach Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 5: Global Stomach Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 6: Global Stomach Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 7: Global Small Intestine Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 8: Global Small Intestine Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 9: Global Small Intestine Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 10: Global Others Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 11: Global Others Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 12: Global Others Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 13: Global Hospitals Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 14: Global Hospitals Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 15: Global Hospitals Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 16: Global Clinics Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 17: Global Clinics Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 18: Global Clinics Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 19: Global Specialized Cancer Treatment Centers Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 20: Global Specialized Cancer Treatment Centers Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 21: Global Specialized Cancer Treatment Centers Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 22: Global Other End Users Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 23: Global Other End Users Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 24: Global Other End Users Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 25: Global Targeted Drug Therapy Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 26: Global Targeted Drug Therapy Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 27: Global Targeted Drug Therapy Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 28: Global Chemotherapy Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 29: Global Chemotherapy Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 30: Global Chemotherapy Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 31: Global Radiation Therapy Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 32: Global Radiation Therapy Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 33: Global Radiation Therapy Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 34: Global Surgery Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 35: Global Surgery Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 36: Global Surgery Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 37: Global Other Therapies Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 38: Global Other Therapies Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 39: Global Other Therapies Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 40: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017

FIG. 41: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026

FIG. 42: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017

FIG. 43: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026

FIG. 44: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017

FIG. 45: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026

FIG. 46: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017

FIG. 47: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026

FIG. 48: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017

FIG. 49: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026

FIG. 50: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017

FIG. 51: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026

FIG. 52: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017

FIG. 53: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026

FIG. 54: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017

FIG. 55: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026

FIG. 56: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017

FIG. 57: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026

FIG. 58: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017

FIG. 59: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026

FIG. 60: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017

FIG. 61: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026

FIG. 62: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017

FIG. 63: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026

FIG. 64: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017

FIG. 65: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026

FIG. 66: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017

FIG. 67: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026

FIG. 68: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017

FIG. 69: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026

FIG. 70: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017

FIG. 71: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026

FIG. 72: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017

FIG. 73: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026

FIG. 74: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017

FIG. 75: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026

FIG. 76: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017

FIG. 77: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026

FIG. 78: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017

FIG. 79: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026

FIG. 80: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017

FIG. 81: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026

FIG. 82: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017

FIG. 83: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026

FIG. 84: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017

FIG. 85: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026

FIG. 86: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017

FIG. 87: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Description

Persistence Market Research has developed an exclusive and in-depth market analysis and forecast for gastrointestinal stromal tumor (GIST). The report covers the expansion of gastrointestinal stromal tumor market across global, regional and local perimeters. The study has been developed to deliver accurate forecast on market size estimations for the assessment period, 2017-2026. From drug development and epidemiology analysis to market entry barriers and changing regulations in the healthcare industry – a range of causative factors for the growth of the global gastrointestinal stromal tumor market have been studied and applied. The impact of these factors is assessed to create presumptive scenarios on how the global gastrointestinal stromal tumor market will expand in the near future.

Companies partaking in the global gastrointestinal stromal tumor market can avail this report to understand the underlying premise of developments in GIST treatments and devise strategies based on the inferences provided in the report. This report serves as a reliable business document for pharmaceutical companies interested in extending their presence in the global gastrointestinal stromal tumor market in the upcoming years.

Report Synopsis

Analysis and forecast on the global gastrointestinal stromal tumor market has been provided in terms of market size estimations. The report includes a slew of sections reveal the estimated forecast on market and its key segments. The report provides an overview of the overall healthcare industry, addressing the latest trends and breakthrough happenings, which puts forth a connection between the changing healthcare landscape and the evolving marketplace for treatments on gastrointestinal stromal tumors.

Cost structure breakdown, pricing analysis, technology trends, FDA pipeline snapshot, and analysis on drug distribution network has been provided in the report as well. The report further delivers a detailed analysis on the competition landscape in the global gastrointestinal stromal tumor market. Current market standings of emerging players and leading companies are disclosed in this section. This report also reveals the strategic developments of market participants to give insights on competitive business growth towards future market direction.

Research Methodology

A team of analysts, research associates, and subject matter experts has developed this report by tracing the key elements instrumenting the growth in the gastrointestinal stromal tumor market. The report has aggregates the revenues that the market participants have procured through GIST treatments over the recent past. This data has been employed to generate baseline for market size forecasting. Metrics such as Year-on-Year growth rate, absolute dollar opportunities, and compounded annual growth rates, have been used to interpret the forecasted data. The overall market size estimations provided in the report are in US dollars (US$). The scope of the report is to deliver accurate forecast on the future of global gastrointestinal stromal tumor market and enable market participants towards taking informed decisions and developing new strategies for business growth. Companies can avail this report to change their presence in the global GIST market and increase their stake in it.

Recommendations

Propylene Glycol Ether Market

The global propylene glycol ether market is estimated to have been valued at US$ 1,604.1 Mn by 2017 end and is expected to reach US$ 2,088.4 Mn by the end of 2026 while expanding at a CAGR of 3.0% over the forecast period. .

Bismuth Market

Global bismuth market is estimated reach around US$ 225 Mn in 2016 and is projected to expand at a moderate single-digit CAGR in terms of value from 2016-2024.

White Spirit Market

White Spirits Market are of four types - Type 1, Type 2, Type 3, and Type 0, which are categorized on their aromatic content basis. White spirits are consumed in a wide range of applications such as paint thinners, cleaning solvents, degreasing solvents, fuels, and disinfectants, among others..

Polyol Ester Market

As per PMR's research study, global polyol ester market anticipated to rise at a robust CAGR of 5.1% along with a healthy revenue during the forecast period of 2017-2027.

Our Clients

Our Clients